A carregar...
Prednisolone Co-Administered with Losartan Confers Renoprotection in Patients with IgA Nephropathy
BACKGROUND: Treatment options for progressive IgA nephropathy are limited. METHODS: We performed a small, randomized controlled trial to evaluate the effects of prednisolone (PSL, 30 mg/dL, gradually tapered to 5 mg/dL over two years) plus 50 mg/day of losartan (LST, an angiotensin II receptor block...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Informa Healthcare
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2409178/ https://ncbi.nlm.nih.gov/pubmed/17497466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08860220701260511 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|